Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation. [electronic resource]
Producer: 20150415Description: 1137-44 p. digitalISSN:- 1532-2092
- Administration, Oral
- Aged
- Anticoagulants -- administration & dosage
- Atrial Fibrillation -- diagnosis
- Benzimidazoles -- administration & dosage
- Catheter Ablation -- adverse effects
- Dabigatran
- Drug Prescriptions
- Drug Utilization Review
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Morpholines -- administration & dosage
- Portugal
- Practice Patterns, Physicians' -- trends
- Prospective Studies
- Risk Assessment
- Risk Factors
- Rivaroxaban
- Thiophenes -- administration & dosage
- Thromboembolism -- etiology
- Time Factors
- Treatment Outcome
- beta-Alanine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.